Alexis Borisy Net Worth & Insider Trades
Alexis Borisy Blueprint Medicines Corp
What is Alexis Borisy's Net Worth?
The current estimated net worth of Blueprint Medicines Corp's Alexis Borisy is estimated to be about $958.4M . Alexis Borisy owns about 60,906 units of Blueprint Medicines Corp common stock. In the last 7 years at Blueprint Medicines Corp, Alexis Borisy has sold an estimated value of $2.01M worth.
What is Alexis Borisy's Past Insider Trading?
Alexis Borisy's largest purchase order was 21,818 units , worth over $715.08K on July 1, 2019. Alexis Borisy's largest sale order was 21,818 units , worth over $2.01M on July 1, 2019. In total, Alexis Borisy has made about 14 transactions over 7 years of their time at Blueprint Medicines Corp. Alexis Borisy usually trades in June, with the busiest year in 2018.
Alexis Borisy
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Alexis Borisy's' Mailing Address?
- Mailing address is C/o Combinatorx, Incorporated 245 First Street, 16th Floor Cambridge MA 02142 MA
Blueprint Medicines Corp Executive Compensation
Name |
Year
|
Salary
|
Total
|
|---|---|---|---|
| Jeffrey W. Albers | 2020 | $645,000 | $6,344,667 |
| Jeffrey W. Albers | 2019 | $590,000 | $9,362,371 |
| Jeffrey W. Albers | 2018 | $541,144 | $9,740,799 |
| Michael Landsittel | 2020 | $379,575 | $2,014,974 |
| Michael Landsittel | 2019 | $345,000 | $1,958,720 |
| Michael Landsittel | 2018 | $281,678 | $1,740,610 |
| Fouad Namouni, M.D. | 2020 | $186,154 | $6,668,732 |
| Fouad Namouni, M.D. | 2019 | - | - |
| Fouad Namouni, M.D. | 2018 | - | - |
| Kathryn Haviland | 2020 | $460,944 | $2,363,556 |
| Kathryn Haviland | 2019 | $431,830 | $3,090,423 |
| Kathryn Haviland | 2018 | $392,589 | $2,601,762 |
| Tracey L. McCain, Esq. | 2020 | $453,301 | $2,346,428 |
| Tracey L. McCain, Esq. | 2019 | $437,972 | $2,900,568 |
| Tracey L. McCain, Esq. | 2018 | $425,216 | $2,647,962 |
| No matching records found | |||
Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm
What are Blueprint Medicines Corp's Past Insider Trades?
Blueprint Medicines Corp's most recent insider trade came on March 8, 2023 by Christopher Murray who sold 1,875 units worth $85.64K . In the last 8 years, insiders at Blueprint Medicines Corp have sold an estimated value of $175.48M and bought an estimated value of $17.63M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Jeffrey Albers, Kate Haviland, CHIEF EXECUTIVE OFFICER, and Ariel Hurley, PRINCIPAL ACCOUNTING OFFICER .
Blueprint Medicines Corp Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||